Latest Blog/News

Layne Brandvik

Layne is the Marketing Associate at Trial Runners. He is passionate about the arts, clinical research, scientific discovery, and environmental issues.

Recent Posts

Why CROs use Risk Based Monitoring

Posted by Layne Brandvik

Risk Based Monitoring is a common practice in the field of clinical trials. Opposed to standard clinical monitoring, Risk based monitoring is "the process of ensuring the quality of clinical trials by identifying, assessing, monitoring and mitigating the risks that could affect the quality or safety of a study." 2

The priority of traditional...

Read More »

The Advantages of Using a Central IRB

Posted by Layne Brandvik

Relationships in any business are a vital part of establishing success in the field of ophthalmic clinical trials. Among those relationships, a CRO must have a working arrangement with an Institutional Review Board, or IRB. An IRB, the team or committee that is tasked with the responsibility of enacting and ensuring the safety of patients...

Read More »

Placing Quality at a premium for your CRO

Posted by Layne Brandvik

Quality is a sector in a standard business professional setting that is universally important and needed, so when that priority is transposed to the needs of an ophthalmology CRO, quality is at a premium. How important is quality to the ophthalmology CRO, and how can one tell that a company shares the ideal that quality is an immediate priority? 

 

Read More »

An Updated exhibitor's survival guide for the ophthalmology cro

Posted by Layne Brandvik

ARVO 2017 is in the books and the conference was bigger and better than ever before. For a premier CRO in the field of ophthalmology, ARVO is a unique opportunity for networking and meeting new people in the industry. ARVO, unlike most conferences in the field, is a lengthy program, spanning over the course of six days with four of those days...

Read More »

Rare Disease in Ophthalmology

Posted by Layne Brandvik

The field Ophthalmology has a substantial number of rare disease representation. Which of these diseases can fall under the definition of of a rare disease, and what can the field of research do to find cures? Below are examples of rare ophthalmic diseases and what the industry has done to treat them. 

Retinoblastoma

Retinoblastoma is a rare...

Read More »

Steps to ensure healthy vision for children

Posted by Layne Brandvik

In the field of ophthalmology, contract research organizations strive towards a common goal to finding cures. Some circles of study focus on the pediatric aspect of medicine, finding cures for genetic or early onset disease indications that affect young children.  In life, accidents happen, and we can only do what we can to protect our children,...

Read More »

Conference Season is Here

Posted by Layne Brandvik

Trial Runners is preparing to hit the road for Conference season this year. The field of ophthalmology offers multipile options for industry thought leaders and presenters to network and share ideas in a forum setting. 

The Clinical Trial Innovation Summit in Boston, MA will be an opportunity for Trial Runners to announce and unveil their new...

Read More »

Gene and stem cell Therapy: The future of Ophthalmology

Posted by Layne Brandvik

Ophthalmic findings, in an effort to finding cures sooner and serving the patients, attach imperative to be on the cutting edge. The future of ophthalmology lies in the utilization  of stem cells to promote tissue growth or gene therapy to introduce a gene via a viral vector to the target tissue for the treatment of eye diseases. Stem cells and...

Read More »

Timelines in Ophthalmic Clinical Research

Posted by Layne Brandvik

 

Timeline achievement is central to a successful clinical trial and pivotal to staying within budget. When approaching a project, a sponsor must address how a CRO approaches timelines. Trial Runners shares the sponsor’s commitment to timeline achievement, not just by meeting established timelines but by establishing the most aggressive in the... Read More »

The Misconceptions of Blindness

Posted by Layne Brandvik

Trial Runners, a full-service ophthalmology CRO, partners with pharmaceutical, biotech and device companies to bring treatments and cures to 1.3 million Americans who are legally blind. While so many patients are afflicted with this debilitating condition, the condition is wrought with misconceptions.

# 1 - Blind people can’t see.

The truth is...

Read More »
1 2 3 4 5